Mucosal immunology, eosinophilic esophagitis, and other intestinal inflammatory diseases

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2 SUPPL. 2, 2010, Pages

  Atkins, Dan ^a,b   Furuta, Glenn T ^a,b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

eosinophilic esophagitis; eosinophilic gastrointestinal diseases; Mucosal immunity

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID DERIVATIVE; ANTIDIARRHEAL AGENT; AZATHIOPRINE; CORTICOSTEROID; FOOD ANTIGEN; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; SPASMOLYTIC AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ADAPTIVE IMMUNITY; ARTICLE; CELIAC DISEASE; CLINICAL FEATURE; COMMENSAL; DEFENSE MECHANISM; ENTERITIS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; GASTROINTESTINAL MUCOSA; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; MEMORY; MICROORGANISM; MUCOSAL IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; EOSINOPHILIA; ESOPHAGITIS; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATION; INTESTINAL MUCOSA;

EID: 76749128812     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.11.037     Document Type: Article

References (73)

1. Cario E. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr Opin Gastroenterol 24 (2008) 725-732
2. Boirivant M., Amendola A., and Butera A. Intestinal microflora and immunoregulation. Mucosal Immunol 1 suppl 1 (2008) S47-S49
3. Artis D., and Grencis R.K. The intestinal epithelium: sensors to effectors in nematode infection. Mucosal Immunol 1 (2008) 252-264
4. Macpherson A.J., McCoy K.D., Johansen F.E., and Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 1 (2008) 11-22
5. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 136 (2009) 65-80
6. Mason K.L., Huffnagle G.B., Noverr M.C., and Kao J.Y. Overview of gut immunology. Adv Exp Med Biol 635 (2008) 1-14
7. Dahan S., Roth-Walter F., Arnaboldi P., Agarwal S., and Mayer L. Epithelia: lymphocyte interactions in the gut. Immunol Rev 215 (2007) 243-253
8. Allez M., Brimnes J., Dotan I., and Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123 (2002) 1516-1526
9. Dotan I., Allez M., Nakazawa A., Brimnes J., Schulder-Katz M., and Mayer L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 292 (2007) G1630-G1640
10. Neutra M.R., Mantis N.J., and Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2 (2001) 1004-1009
11. Jang M.H., Kweon M.N., Iwatani K., Yamamoto M., Terahara K., Sasakawa C., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A 101 (2004) 6110-6115
12. Himmel M.E., Hardenberg G., Piccirillo C.A., Steiner T.S., and Levings M.K. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 125 (2008) 145-153
13. Galli S.J., and Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 49 (2008) 7-19
14. Koon H.W., and Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 1088 (2006) 23-40
15. Blanchard C., and Rothenberg M.E. Biology of the eosinophil. Adv Immunol 101 (2009) 81-121
16. Blanchard C., and Rothenberg M.E. Chemotactic factors associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am 29 (2009) 141-148 xi
17. Hogan S.P., and Rothenberg M.E. Eosinophil function in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 6 (2006) 65-71
18. McGuckin M.A., Eri R., Simms L.A., Florin T.H., and Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15 (2009) 100-113
19. Kjellev S. The trefoil factor family-small peptides with multiple functionalities. Cell Mol Life Sci 66 (2009) 1350-1369
20. Suzuki K., and Fagarasan S. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol 29 (2008) 523-531
21. Evolution F.S. development, mechanism and function of IgA in the gut. Curr Opin Immunol 20 (2008) 170-177
22. Braff M.H., Hawkins M.A., Di Nardo A., Lopez-Garcia B., Howell M.D., Wong C., et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174 (2005) 4271-4278
23. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
24. Ericksen B., Wu Z., Lu W., and Lehrer R.I. Antibacterial activity and specificity of the six human α-defensins. Antimicrob Agents Chemother 49 (2005) 269-275
25. Bilsborough J., and Viney J.L. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127 (2004) 300-309
26. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204 (2007) 1757-1764
27. Shanahan F., and Bernstein C.N. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 25 (2009) 301-305
28. van Lierop P.P., Samsom J.N., Escher J.C., and Nieuwenhuis E.E. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48 (2009) 142-151
29. Round J.L., and Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (2009) 313-323
30. Weinstock J.V., and Elliott D.E. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 15 (2009) 128-133
31. Yoshida H., and Granger D.N. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis 15 (2009) 1245-1255
32. Abraham C., and Cho J. Inflammatory bowel disease. N Engl J Med 361 (2009) 2066-2078
33. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schaffer A.A., Noyan F., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361 (2009) 2033-2045
34. Abraham C., and Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 60 (2009) 97-110
35. Yamamoto T., Nakahigashi M., and Saniabadi A.R. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther 30 (2009) 99-112
36. Regueiro M. Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis 15 (2009) 1583-1590
37. Rutgeerts P., Vermeire S., and Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 136 (2009) 1182-1197
38. Hunt K.A., and van Heel D.A. Recent advances in coeliac disease genetics. Gut 58 (2009) 473-476
39. Barker J.M., and Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr 55 (2008) 349-365
40. Freeman H.J. Pearls and pitfalls in the diagnosis of adult celiac disease. Can J Gastroenterol 22 (2008) 273-280
41. Molberg O., Uhlen A.K., Jensen T., Flaete N.S., Fleckenstein B., Arentz-Hansen H., et al. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology 128 (2005) 393-401
42. Schumann M., Richter J.F., Wedell I., Moos V., Zimmermann-Kordmann M., Schneider T., et al. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut 57 (2008) 747-754
43. Haines M.L., Anderson R.P., and Gibson P.R. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 28 (2008) 1042-1066
44. Fleischer D.M., and Atkins D. Evaluation of the patient with suspected eosinophilic gastrointestinal disease. Immunol Allergy Clin North Am 29 (2009) 53-63 ix
45. Straumann A. Idiopathic eosinophilic gastrointestinal diseases in adults. Best Pract Res Clin Gastroenterol 22 (2008) 481-496
46. Atkins D., Kramer R., Capocelli K., Lovell M., and Furuta G.T. Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol 6 (2009) 267-278
47. Leslie C., Mews C., Charles A., and Ravikumara M. Celiac disease and eosinophilic esophagitis: a true association. J Pediatr Gastroenterol Nutr (2009) [Epub ahead of print]
48. Verzegnassi F., Bua J., De Angelis P., Dall'oglio L., Di Leo G., and Ventura A. Eosinophilic oesophagitis and coeliac disease: is it just a casual association?. Gut 56 (2007) 1029-1030
49. Ooi C.Y., Day A.S., Jackson R., Bohane T.D., Tobias V., and Lemberg D.A. Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol 23 (2008) 1144-1148
50. Kagalwalla A.F., Shah A., Ritz S., Melin-Aldana H., and Li B.U. Cow's milk protein-induced eosinophilic esophagitis in a child with gluten-sensitive enteropathy. J Pediatr Gastroenterol Nutr 44 (2007) 386-388
51. Furuta G.T., Liacouras C.A., Collins M.H., Gupta S.K., Justinich C., Putnam P.E., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133 (2007) 1342-1363
52. Spergel J.M., Brown-Whitehorn T.F., Beausoleil J.L., Franciosi J., Shuker M., Verma R., et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 48 (2009) 30-36
53. Haas A., and Creskoff-Naune N. Feeding dysfunction in children with eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) In press
54. Desai T.K., Stecevic V., Chang C.H., Goldstein N.S., Badizadegan K., and Furuta G.T. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 61 (2005) 795-801
55. Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointest Endosc Clin North Am 18 (2008) 99-118 ix
56. Konikoff M.R., Blanchard C., Kirby C., Buckmeier B.K., Cohen M.B., Heubi J.E., et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 4 (2006) 1328-1336
57. Souza R.F., Huo X., Mittal V., Schuler C.M., Carmack S.W., Zhang H.Y., et al. Gastroesophageal reflux may cause esophagitis through a cytokine-mediated mechanism, not by caustic (acid) injury. Gastroenterology 137 (2009) 1776-1784
58. Blanchard C., Wang N., Stringer K.F., Mishra A., Fulkerson P.C., Abonia J.P., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 (2006) 536-547
59. Mishra A., Hogan S.P., Brandt E.B., and Rothenberg M.E. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168 (2002) 2464-2469
60. Tantibhaedhyangkul U., Tatevian N., Gilger M.A., Major A.M., and Davis C.M. Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. Ann Clin Lab Sci 39 (2009) 99-107
61. Zhu X., Wang M., Crump C.H., and Mishra A. An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice. Am J Physiol Gastrointest Liver Physiol 297 (2009) G550-G558
62. Mishra A., Wang M., Pemmaraju V.R., Collins M.H., Fulkerson P.C., Abonia J.P., et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 134 (2008) 204-214
63. Protheroe C., Woodruff S.A., de Petris G., Mukkada V., Ochkur S.I., Janarthanan S., et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 7 (2009) 749-755 e11
64. Vicario M., Blanchard C., Stringer K.F., Collins M.H., Mingler M.K., Ahrens A., et al. Local B cells and IgE production in the esophageal mucosa in eosinophilic esophagitis. Gut (2009) [Epub ahead of print]
65. Blanchard C., Durual S., Estienne M., Emami S., Vasseur S., and Cuber J.C. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int J Biochem Cell Biol 37 (2005) 2559-2573
66. Bhattacharya B., Carlsten J., Sabo E., Kethu S., Meitner P., Tavares R., et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 38 (2007) 1744-1753
67. Chehade M., Sampson H.A., Morotti R.A., and Magid M.S. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45 (2007) 319-328
68. Aceves S.S., Newbury R.O., Dohil R., Bastian J.F., and Broide D.H. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 119 (2007) 206-212
69. Aceves S.S., Newbury R.O., Chen D., Mueller J., Dohil R., Hoffman H., et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy (2009) [Epub ahead of print]
70. Spergel J.M., Andrews T., Brown-Whitehorn T.F., Beausoleil J.L., and Liacouras C.A. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 95 (2005) 336-343
71. Spergel J.M., Beausoleil J.L., Mascarenhas M., and Liacouras C.A. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 109 (2002) 363-368
72. Klinnert M.D. Psychological impact of eosinophilic esophagitis on children and families. Immunol Allergy Clin North Am 29 (2009) 99-107 x
73. Rothenberg M.E. Biology and treatment of eosinophilic esophagitis. Gastroenterology 137 (2009) 1238-1249